CLAY BARBIN: Open Payments
NPI 1659715696 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 26 payments from 14 companies in 2025. Trend: 2023 $946 · 2024 $1,649 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $435 |
| Cleerly, Inc. | 4 | $289 |
| ABIOMED | 3 | $250 |
| Penumbra, Inc. | 1 | $137 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Bard Peripheral Vascular, Inc. | 1 | $35 |
| Bracco Diagnostics Inc. | 1 | $30 |
Products named: Cleerly Ischemia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, DRAGONFLY OPSTAR, Indigo System, AVEIR, CAMZYOS, JARDIANCE, ONPATTRO.
Industry payments across TX — which companies pay providers there.
